Life Science Matters An inside look at the latest legal developments involving medical devices, pharmaceuticals, and more

  • Home
  • About
  • Categories
    • ANDA
    • Class Action
    • Coronavirus
    • Daubert
    • Design Defect
    • FDA
    • IP
    • Labeling
    • Medical Device
    • News
    • Nutritional Supplements
    • Off Label
    • Pharmacy
    • Pharmaceuticals
    • Preemption
    • Recalls
    • Regulatory
    • Sales Representatives
    • Settlements
    • Supplements
    • Verdicts
  • Resources
  • Subscribe
  • Contact Us

This Week’s Life Science Headlines

  • October 31, 2013
  • /
  • FDA Medical Device News Pharmaceuticals Recalls Regulatory Settlements Verdicts
  • /
  • Life Science Matters
        Litigation
  • 6th Circ. Won’t Hear Appeal of Darvocet Suit Remand (subscription required)
  • Okla. Supreme Court Gives Harsh Take on Abortion Drug Law (subscription required)
  • Takeaways from McPhee v. DePuy’s Preemption Pronouncement (subscription required)
  • Canadian Court Won’t Shrink Paxil Birth Defect Class (subscription required)
  • Major Medical Device Manufacturer Agrees to Pay $13.2 Million to Settle Foreign Corrupt Practices Act (FCPA) Charges
  • Dow Seeks En Banc Review of Cancer Cluster Suit (subscription required)
  • Lumina Diet Supplement Class Action Stays in Fed. Court
…
Continue reading...
  • 2013 medical device development report 6th Circuit Abbott Abortion Drug Law ANDAs App oversight Avandia boehringer ingelheim brovana cancer cluster suit civil bribery charges Class Action codman Davocet DePuy's Dow draeger drug promotion e-Learning course EU Parliament evaluating drug promotion fabius series anesthesia machines failure of automatic ventilator FCPA Foreign Corrupt Practices Act GSK hydrocone inclusig insulin pens leaking heart valve lumina diet supplement McPhee medstream programmable infusion pump novo nordisk Oklahoma Supreme Court Paxil birth defect ponatinib post-market studies pradaxa RICO shurtleff sunovion vicodin webinar wrongful death suit
Goldberg Segalla

Search

Categories

  • Posts
  • Multicounty Litigation Order in New Jersey Provides No Guidance to Practitioners June 23, 2021
  • New Multicounty Litigation Application in New Jersey June 8, 2021
  • Lack of Agreement to Arbitrate Dooms Bid to Compel Arbitration May 26, 2021
  • Mixed Bag in New Jersey Medical Device Preemption Opinion May 12, 2021
  • First Circuit Agrees Pharmacists Provide Services, Not Sell Goods April 27, 2021

About Us

Goldberg Segalla is a national civil litigation firm with more than 20 offices in 10 states spanning major metro markets across the U.S., providing strategic coverage wherever our clients do business. As a firm of experienced litigators and trial attorneys, our capabilities span business and commercial disputes, employment and labor, insurance coverage, product liability, and more. Today, our nearly 400 attorneys are trusted counselors to public and private clients in key sectors and industries including construction and energy, transportation, manufacturing, retail and hospitality, and insurance.

Links

  • Home
  • About
  • Resources
  • Contact Us
Copyright 2023 · Goldberg Segalla